Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Takeaki Satoh
Cost-Effectiveness Analysis of Sofosbuvir Plus Ribavirin in Patients With Genotype 2 Chronic Hepatitis C: An Analysis With Real World Outcomes From a Multicentre Cohort in Japan
BMJ Open
Medicine
Related publications
Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Genotype 3a in Pakistani Population - A Real World Experience
Pakistan Journal of Medical Sciences
Medicine
Efficacy and Safety of Ribavirin With Sofosbuvir Plus Ledipasvir in Patients With Genotype 1 Hepatitis C: A Meta-Analysis
Digestive Diseases and Sciences
Physiology
Gastroenterology
Sofosbuvir Plus Daclatasvir With or Without Ribavirin in 551 Patients With Hepatitis C-Related Cirrhosis, Genotype 4
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Utility Analysis of Sofosbuvir for Treatment of Genotype2 Chronic Hepatitis C in Japan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ledipasvir / Sofosbuvir for the Treatment of Chronic Hepatitis C: A Cost-Effectiveness Analysis Across Different Genotype 1 Clinical Subgroups
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection
JAMA - Journal of the American Medical Association
Medicine
An Index to Predict Ribavirin-Induced Anemia in Asian Patients With Chronic Genotype 1 Hepatitis C
Hepatitis Monthly
Hepatology
Infectious Diseases
Daclatasvir and Sofosbuvir With Ribavirin for 24 Weeks in Chronic Hepatitis C Genotype-3-Infected Patients With Cirrhosis: A Phase III Study (ALLY-3C)
Antiviral Therapy
Infectious Diseases
Pharmacology
